The UK government has set out its goals for Brexit negotiations, with ensuring the country “remains the best place for science and innovation” among its 12 objectives.
Prime minister Theresa May has been accused of being "in denial" about a crisis in the National Health Service caused by huge demand and limited resources.
UK pharma trade organisation the ABPI says a so-called ‘quickie divorce’ exit from the European Union is not an option for medicines, as patients cannot have their supply of medicines interrupt
Prime Minister Theresa May has hinted that the UK could seek a transition deal to allow the country to avoid a ‘cliff edge’ effect of leaving the European Union.
Daniel Ghinn examines the reactions of healthcare professionals to the new Prime Minister’s decision to keep Jeremy Hunt in her cabinet as Health Secretary.
The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient
On 1st October, the roll-out of the National Contract Value Review (NCVR) process marked a pivotal moment in the trajectory of clinical research in the UK, introducing a standardised, natio